Join Our Team

Career Opportunities

To be a part of our pioneering team of scientific investigators, please check our open positions. For consideration, please send your resume to us at careers@fatetherapeutics.com and reference the open position’s job code.

Open Positions

254JB, Regulatory Affairs Operations Manager

Job Code 254JB

Description

Fate Therapeutics, Inc. is seeking an experienced and highly motivated regulatory professional to support Regulatory Affairs Operations. This is a full-time position reporting to the Executive Director, Regulatory Affairs. The Regulatory Affairs Operations Manager will be responsible for operational aspects of all regulatory submissions, ensuring that the submissions are of the highest quality and submitted on-time. The position will also support the compilation, archiving, and tracking of regulatory submissions and health authority correspondence in partnership with Regulatory Program Management, cross-functional Teams, and external partners. Emphasis will be on strategic planning, management, and execution of all aspects of Regulatory Affairs Operations.

Download a PDF of the job description for more details:

View PDF

For consideration send cover letter and curriculum vitae to: careers@fatetherapeutics.com and reference job 254JB.

About Fate Therapeutics, Inc.

Fate Therapeutics is a biopharmaceutical company dedicated to the development of programmed cellular immunotherapeutics for the treatment of cancer and immune disorders. The Company’s cell-based product candidate pipeline is comprised of off-the-shelf immuno-oncology therapeutics, including NK- and T-cell-based candidates derived from induced pluripotent cells, and immuno-regulatory therapeutics, including hematopoietic cell-based candidates for protecting the immune system of patients undergoing hematopoietic cell transplantation and for suppressing auto-reactive T cells of patients with auto-immune disorders. Its adoptive cell therapy candidates are based on the Company’s novel ex vivo cell programming approach, which it applies to modulate the therapeutic function and direct the fate of immune cells.

253DL, Clinical Trial Associate

Job Code 253DL

Description

Fate’s clinical operations group is seeking a motivated and talented individual to support development and management of an electronic trial master file system (Veeva) and assist our clinical trial managers with administrative and project-specific support related to the conduct of clinical studies. The successful candidate will assure adherence to protocol(s) and GCP/ICH guidelines and applicable regulations. The ideal candidate will be familiar with phase I-IV protocols and have hands-on experience in developing and maintaining electronic clinical trial management systems. Candidates must thrive in a fast-paced team environment. Excellent communication, organizational abilities, and independent problem-solving skills are a must. This is a full-time position reporting to the Senior Manager, Clinical Operations, and is located at our company’s headquarters in San Diego, California.

Download a PDF of the job description for more details:

View PDF

For consideration send cover letter and curriculum vitae to: careers@fatetherapeutics.com and reference job 253DL.

About Fate Therapeutics, Inc.

Fate Therapeutics is a biopharmaceutical company dedicated to the development of programmed cellular immunotherapeutics for the treatment of cancer and immune disorders. The Company’s cell-based product candidate pipeline is comprised of off-the-shelf immuno-oncology therapeutics, including NK- and T-cell-based candidates derived from induced pluripotent cells, and immuno-regulatory therapeutics, including hematopoietic cell-based candidates for protecting the immune system of patients undergoing hematopoietic cell transplantation and for suppressing auto-reactive T cells of patients with auto-immune disorders. Its adoptive cell therapy candidates are based on the Company’s novel ex vivo cell programming approach, which it applies to modulate the therapeutic function and direct the fate of immune cells.

252MB, Senior Research Associate, Process Development

Job Code 252MB

Description

Fate Therapeutics is seeking a highly motivated, skilled, and conscientious individual to join our company’s Process Development team to support the development of pluripotent cell-derived therapies. The successful candidate will join a multidisciplinary team pursuing the derivation of hematopoietic cells, particularly engineered hematopoietic progenitor stem cells (eHPSCs), from iPSCs for cellular therapeutic purposes. The candidate will perform, optimize and analyze experiments involving the in vitro differentiation, expansion and production of iPSCs towards eHPSCs. Candidates must have extensive cell culture experience with impeccable aseptic bioprocessing techniques, and a knowledge of embryonic stem cells is preferred. This position is located at our corporate headquarters in San Diego, California and reports to the Scientist, Process Development.

Download a PDF of the job description for more details:

View PDF

For consideration send cover letter and curriculum vitae to: careers@fatetherapeutics.com and reference job 252MB.

About Fate Therapeutics, Inc.

Fate Therapeutics is a biopharmaceutical company dedicated to the development of programmed cellular immunotherapeutics for the treatment of cancer and immune disorders. The Company’s cell-based product candidate pipeline is comprised of off-the-shelf immuno-oncology therapeutics, including NK- and T-cell-based candidates derived from induced pluripotent cells, and immuno-regulatory therapeutics, including hematopoietic cell-based candidates for protecting the immune system of patients undergoing hematopoietic cell transplantation and for suppressing auto-reactive T cells of patients with auto-immune disorders. Its adoptive cell therapy candidates are based on the Company’s novel ex vivo cell programming approach, which it applies to modulate the therapeutic function and direct the fate of immune cells.

251WW, Senior Director, Manufacturing Science and Technology (MSAT)

Job Code 251WW

Description

Fate Therapeutics is seeking a highly motivated Senior Director, Manufacturing Science and Technology (MSAT), to provide technical and organizational leadership to develop solutions in support of clinical and commercial manufacturing for internal and external manufacturing operations. The position will provide program leadership for IND projects, liaison with Manufacturing, Process Science and Assay Development, Quality Assurance, Quality Control, Regulatory, Clinical and various project stakeholders to promote Product Development aims. The successful candidate will act as a Fate representative during interactions with US and international regulatory bodies and participate in CMC leadership team to set annual objectives. Fate’s development programs involve novel cell therapies which present with unique product manufacturing, quality and regulatory challenges. The ideal candidate should have experience in the area of cell therapy and/or biologics and be aware of the pertinent regulations and how they apply to these fields. This is a full-time position reporting to the SVP, Technical Operations and is located at our corporate headquarters in San Diego, CA.

Download a PDF of the job description for more details:

View PDF

For consideration send cover letter and curriculum vitae to: careers@fatetherapeutics.com and reference job 251WW.

About Fate Therapeutics, Inc.

Fate Therapeutics is a biopharmaceutical company dedicated to the development of programmed cellular immunotherapeutics for the treatment of cancer and immune disorders. The Company’s cell-based product candidate pipeline is comprised of off-the-shelf immuno-oncology therapeutics, including NK- and T-cell-based candidates derived from induced pluripotent cells, and immuno-regulatory therapeutics, including hematopoietic cell-based candidates for protecting the immune system of patients undergoing hematopoietic cell transplantation and for suppressing auto-reactive T cells of patients with auto-immune disorders. Its adoptive cell therapy candidates are based on the Company’s novel ex vivo cell programming approach, which it applies to modulate the therapeutic function and direct the fate of immune cells.

250RB, Senior Scientist, Cancer Immunotherapy (NK Group)

Job Code 250RB

Description

Fate Therapeutics is seeking a highly motivated immunologist to join our rapidly growing cancer immunotherapy team in the development of novel NK cell therapeutics. The position of Senior Scientist, Cancer Immunotherapy will provide scientific and technical expertise contributing to the development and characterization of novel immunotherapies from discovery stage through product development. The successful candidate will perform, optimize, and analyze experiments and data involving NK and T cell characterization, proliferation, survival, and function. In addition, this role will have the opportunity to provide subject matter expertise and direction to regulatory, process development, and clinical teams. The qualified candidate is a motivated, interactive, and creative scientist with a track record of successful and independent laboratory investigation. Previous industry experience is preferred. Previous leadership experience is highly desired, as is experience and success working in a cross-functional and collaborative scientific environment. An ideal candidate would possess experience characterizing immune cells through cell activation and cytotoxicity assays, cytokine profiling, multi-color flow cytometry analysis including intracellular staining, and in vivo models, with a preference for experience with in vivo xenograft models. This position reports to the Associate Director, Cancer Immunotherapy and is located at our corporate headquarters in San Diego, California.

Download a PDF of the job description for more details:

View PDF

For consideration send cover letter and curriculum vitae to: careers@fatetherapeutics.com and reference job 250RB.

About Fate Therapeutics, Inc.

Fate Therapeutics is a biopharmaceutical company dedicated to the development of programmed cellular immunotherapeutics for the treatment of cancer and immune disorders. The Company’s cell-based product candidate pipeline is comprised of off-the-shelf immuno-oncology therapeutics, including NK- and T-cell-based candidates derived from induced pluripotent cells, and immuno-regulatory therapeutics, including hematopoietic cell-based candidates for protecting the immune system of patients undergoing hematopoietic cell transplantation and for suppressing auto-reactive T cells of patients with auto-immune disorders. Its adoptive cell therapy candidates are based on the Company’s novel ex vivo cell programming approach, which it applies to modulate the therapeutic function and direct the fate of immune cells.

249EP, Senior Research Associate / Research Associate, Cancer Immunotherapy

Job Code 249EP

Description

Fate Therapeutics is currently seeking a motivated, conscientious, and talented individual with experience in Immunology or a related field. This person will assist our immunology teams in performing in vitro and ex vivo experiments to characterize primary and iPSC-derived CAR-T cells. This is a full-time position located at the Company’s corporate headquarters in San Diego.

Download a PDF of the job description for more details:

View PDF

For consideration send cover letter and curriculum vitae to: careers@fatetherapeutics.com and reference job 249EP.

About Fate Therapeutics, Inc.

Fate Therapeutics is a biopharmaceutical company dedicated to the development of programmed cellular immunotherapeutics for the treatment of cancer and immune disorders. The Company’s cell-based product candidate pipeline is comprised of off-the-shelf immuno-oncology therapeutics, including NK- and T-cell-based candidates derived from induced pluripotent cells, and immuno-regulatory therapeutics, including hematopoietic cell-based candidates for protecting the immune system of patients undergoing hematopoietic cell transplantation and for suppressing auto-reactive T cells of patients with auto-immune disorders. Its adoptive cell therapy candidates are based on the Company’s novel ex vivo cell programming approach, which it applies to modulate the therapeutic function and direct the fate of immune cells.

248DR, Scientist, Genome Biology

Job Code 248DR

Description

Fate Therapeutics is currently seeking a talented and highly motivated scientist with a strong background in Next Generation Sequencing (NGS) and single cell characterization methods to join a multidisciplinary team dedicated to the discovery of novel iPSC derived cellular therapeutics. The candidate will play a key role in NGS method development to perform genomic and transcriptomic characterization on immune cells in the tumor microenvironment including Fate’s engineered iPSC derived T and NK cell cancer immunotherapy products. The successful candidate must have knowledge of current genomic engineering techniques (Lentivirus, CRISPR, etc.) as well as strong expertise in genomic and transcriptomic characterization of genetically modified cells using NGS, preferably in a single-cell environment. The position will require innovative thinking, strong independent and collaborative research abilities, and excellent oral and written communication skills. This is a full-time, bench-level position reporting to the Associate Director, Genomics and is located at the Company’s corporate headquarters in San Diego, California.

Download a PDF of the job description for more details:

View PDF

For consideration send cover letter and curriculum vitae to: careers@fatetherapeutics.com and reference job 248DR.

About Fate Therapeutics, Inc.

Fate Therapeutics is a biopharmaceutical company dedicated to the development of programmed cellular immunotherapeutics for the treatment of cancer and immune disorders. The Company’s cell-based product candidate pipeline is comprised of off-the-shelf immuno-oncology therapeutics, including NK- and T-cell-based candidates derived from induced pluripotent cells, and immuno-regulatory therapeutics, including hematopoietic cell-based candidates for protecting the immune system of patients undergoing hematopoietic cell transplantation and for suppressing auto-reactive T cells of patients with auto-immune disorders. Its adoptive cell therapy candidates are based on the Company’s novel ex vivo cell programming approach, which it applies to modulate the therapeutic function and direct the fate of immune cells.

245PR, Scientist / Associate Scientist Cancer Immunotherapy

Job Code 245PR

Description

Fate Therapeutics is seeking a motivated, conscientious, and analytic scientist or associate scientist to join our cancer immunotherapy team. The position focuses on developing in vitro assays and optimizing culture methodologies for both iPSC-derived NK and T cell therapy products. The candidate will perform in-depth analysis of Fate cell products using multi-color flow cytometry, cytotoxic and ELISA-based immunoassays to assess proliferation, survival, phenotype, and function. Strong candidates will be well-versed in cellular immunology and have a track record of successful problem solving, data analysis, and experimental planning/execution. Experience with a broad range of immunological assays including characterization of immune cells through cell activation and cytotoxicity assays, cytokine profiling, and multi-color flow cytometry analysis is essential, and knowledge of large-scale cell production and bioreactors is a plus. This position reports to the Senior Scientist, cancer immunotherapy and is located at our corporate headquarters in San Diego, California.

Download a PDF of the job description for more details:

View PDF

For consideration send cover letter and curriculum vitae to: careers@fatetherapeutics.com and reference job 245PR.

About Fate Therapeutics, Inc.

Fate Therapeutics is a biopharmaceutical company dedicated to the development of programmed cellular immunotherapeutics for the treatment of cancer and immune disorders. The Company’s cell-based product candidate pipeline is comprised of off-the-shelf immuno-oncology therapeutics, including NK- and T-cell-based candidates derived from induced pluripotent cells, and immuno-regulatory therapeutics, including hematopoietic cell-based candidates for protecting the immune system of patients undergoing hematopoietic cell transplantation and for suppressing auto-reactive T cells of patients with auto-immune disorders. Its adoptive cell therapy candidates are based on the Company’s novel ex vivo cell programming approach, which it applies to modulate the therapeutic function and direct the fate of immune cells.

244MW, Research Associate, Translational Science (Histology)

Job Code 244MW

Description

Fate Therapeutics is currently seeking a talented and highly motivated research associate with a strong background in Microscopy and Histology to join a multidisciplinary team dedicated to the discovery of novel cellular therapeutics. The candidate will play a key role in developing novel translational science assays to perform microscopic characterization of Fate’s therapeutic cells, including human natural killer (NK) and T cells within the tumor environment. The successful candidate must have strong expertise in standard tissue histology techniques including fixing and parrafin embedding, fresh frozen tissue, cutting and mounting tissue sections, and staining tissue sections with antibodies and/or nucleic acid probes. Some fluorescence microscopy experience is preferred but not required. Experience with molecular imaging methods (e.g. fluorescence in situ hybirdataion [FISH]), flow cytometry, ELISA or other standard lab methods would be preferred but not required. The position will require innovative thinking, strong independent and collaborative research abilities, and excellent oral and written communication skills. This is a full-time, bench-level position reporting to the Senior Scientist, Translational Medicine and is located at the Company’s corporate headquarters in San Diego, California.

Download a PDF of the job description for more details:

View PDF

For consideration send cover letter and curriculum vitae to: careers@fatetherapeutics.com and reference job 244MW.

About Fate Therapeutics, Inc.

Fate Therapeutics is a biopharmaceutical company dedicated to the development of programmed cellular immunotherapeutics for the treatment of cancer and immune disorders. The Company’s cell-based product candidate pipeline is comprised of off-the-shelf immuno-oncology therapeutics, including NK- and T-cell-based candidates derived from induced pluripotent cells, and immuno-regulatory therapeutics, including hematopoietic cell-based candidates for protecting the immune system of patients undergoing hematopoietic cell transplantation and for suppressing auto-reactive T cells of patients with auto-immune disorders. Its adoptive cell therapy candidates are based on the Company’s novel ex vivo cell programming approach, which it applies to modulate the therapeutic function and direct the fate of immune cells.

243LR, Senior Manager / Manager, Quality Assurance

Job Code 243LR

Description

Fate Therapeutics is seeking an experienced and motivated Manager of Quality Assurance to support Fate’s internal and external cGMP manufacturing operations. The successful candidate must thrive in a fast-paced team environment, have excellent communication, planning and organizational skills, and manage quality assurance activities to meet Fate’s priorities and timelines. The candidate must have experience and a proven track record of establishing and maintaining a quality management system to support GXP-compliant manufacturing operations and will be expected to effectively follow Fate’s SOPs and policies. This is a full-time position reporting to the Quality Assurance Associate Director and is located at our corporate headquarters in San Diego, California.

Download a PDF of the job description for more details:

View PDF

For consideration send cover letter and curriculum vitae to: careers@fatetherapeutics.com and reference job 243LR.

About Fate Therapeutics, Inc.

Fate Therapeutics is a biopharmaceutical company dedicated to the development of programmed cellular immunotherapeutics for the treatment of cancer and immune disorders. The Company’s cell-based product candidate pipeline is comprised of off-the-shelf immuno-oncology therapeutics, including NK- and T-cell-based candidates derived from induced pluripotent cells, and immuno-regulatory therapeutics, including hematopoietic cell-based candidates for protecting the immune system of patients undergoing hematopoietic cell transplantation and for suppressing auto-reactive T cells of patients with auto-immune disorders. Its adoptive cell therapy candidates are based on the Company’s novel ex vivo cell programming approach, which it applies to modulate the therapeutic function and direct the fate of immune cells.

242KP, Research Associate, Cell Therapy

Job Code 242KP

Description

Fate Therapeutics is seeking a motivated, conscientious, and talented cell biologist to support the company’s process development group, pursuing the derivation of natural killer (NK) cells from induced pluripotent stem cells (iPSCs) for use in cell therapy applications. The successful candidate will support experiments involving iPSC maintenance and expansion, in vitro differentiation of iPSCs towards the hematopoietic lineages, and further differentiation and expansion of NK cells. Candidates must have cell culture experience; knowledge of stem cell biology, the hematopoietic system, and immunology is preferred. This position will require independent research and coordination with the process development group. This is a full-time position requiring dedicated weekend hours and is located at our corporate headquarters in San Diego, CA.

Download a PDF of the job description for more details:

View PDF

For consideration send cover letter and curriculum vitae to: careers@fatetherapeutics.com and reference job 242KP.

About Fate Therapeutics, Inc.

Fate Therapeutics is a biopharmaceutical company dedicated to the development of programmed cellular immunotherapeutics for the treatment of cancer and immune disorders. The Company’s cell-based product candidate pipeline is comprised of off-the-shelf immuno-oncology therapeutics, including NK- and T-cell-based candidates derived from induced pluripotent cells, and immuno-regulatory therapeutics, including hematopoietic cell-based candidates for protecting the immune system of patients undergoing hematopoietic cell transplantation and for suppressing auto-reactive T cells of patients with auto-immune disorders. Its adoptive cell therapy candidates are based on the Company’s novel ex vivo cell programming approach, which it applies to modulate the therapeutic function and direct the fate of immune cells.

239AL, Quality Control Associate

Job Code 239AL

Description

Fate Therapeutics is seeking a motivated professional with qPCR, flow cytometry and cell-based assay experience to support Fate’s clinical and manufacturing process development programs. The successful candidate will execute and analyze experiments to assess the characteristics of hematopoietic and stem cell-based therapeutics under cGMP environment. Candidates must have experience working with mammalian cell culture, and analysis of data from cell-based assays, especially qPCR or flow cytometry. This is a full-time position located at our corporate headquarters in San Diego.

Download a PDF of the job description for more details:

View PDF

For consideration send cover letter and curriculum vitae to: careers@fatetherapeutics.com and reference job 239AL.

About Fate Therapeutics, Inc.

Fate Therapeutics is a biopharmaceutical company dedicated to the development of programmed cellular immunotherapeutics for the treatment of cancer and immune disorders. The Company’s cell-based product candidate pipeline is comprised of off-the-shelf immuno-oncology therapeutics, including NK- and T-cell-based candidates derived from induced pluripotent cells, and immuno-regulatory therapeutics, including hematopoietic cell-based candidates for protecting the immune system of patients undergoing hematopoietic cell transplantation and for suppressing auto-reactive T cells of patients with auto-immune disorders. Its adoptive cell therapy candidates are based on the Company’s novel ex vivo cell programming approach, which it applies to modulate the therapeutic function and direct the fate of immune cells.

237JG, Scientist / Engineer, Cancer Immunotherapy

Job Code 237JG

Description

Fate Therapeutics is seeking an aspiring scientist or engineer to join our rapidly growing cancer immunotherapy team in developing novel iPSC derived NK cell and T cell therapeutics. The position involves focused development and execution of in vivo and in vitro assays critical to our evaluation of cell-based immunotherapy products currently under preclinical development, and in the future establishment of novel science-driven iPSC derived cell therapy products. A successful candidate will have the necessary skills and experience to independently perform characterization of immune cell phenotype and functions, application of disease models and cell-based therapies in vivo and detailed analysis of immunological experiments involving NK and T cell proliferation, survival, and function. A necessary foundation in immunology and experience with a broad range of immunological and cell biological assays is required, including familiarity with multi-color flow cytometry, ELISA, gene expression analysis and molecular biology. Previous cell culture experience, particularly with primary immune cells, is preferred. This position reports to the Senior Scientist, Cancer Immunotherapy and is located at our corporate headquarters in San Diego, California.

Download a PDF of the job description for more details:

View PDF

For consideration send cover letter and curriculum vitae to: careers@fatetherapeutics.com and reference job 237JG.

About Fate Therapeutics, Inc.

Fate Therapeutics is a biopharmaceutical company dedicated to the development of programmed cellular immunotherapeutics for the treatment of cancer and immune disorders. The Company’s cell-based product candidate pipeline is comprised of off-the-shelf immuno-oncology therapeutics, including NK- and T-cell-based candidates derived from induced pluripotent cells, and immuno-regulatory therapeutics, including hematopoietic cell-based candidates for protecting the immune system of patients undergoing hematopoietic cell transplantation and for suppressing auto-reactive T cells of patients with auto-immune disorders. Its adoptive cell therapy candidates are based on the Company’s novel ex vivo cell programming approach, which it applies to modulate the therapeutic function and direct the fate of immune cells.

235JB, Director / Associate Director, Business Development

Job Code 235JB

Description

Fate Therapeutics is currently seeking a Director or Associate Director, Business Development. The primary responsibilities of this strategic position are business development activities required for identifying, evaluating, and facilitating high-value transactions including collaborative partnerships which have a direct impact on the strategic evolution of the Company. Secondary responsibilities include business analytics and strategy to support key business development decisions, competitive intelligence, and alliance management. This is a full-time position reporting to the Senior Vice President, Corporate Development and is located at our corporate headquarters in San Diego, CA.

Download a PDF of the job description for more details:

View PDF

For consideration send cover letter and curriculum vitae to: careers@fatetherapeutics.com and reference job 235JB.

About Fate Therapeutics, Inc.

Fate Therapeutics is a biopharmaceutical company dedicated to the development of programmed cellular immunotherapeutics for the treatment of cancer and immune disorders. The Company’s cell-based product candidate pipeline is comprised of off-the-shelf immuno-oncology therapeutics, including NK- and T-cell-based candidates derived from induced pluripotent cells, and immuno-regulatory therapeutics, including hematopoietic cell-based candidates for protecting the immune system of patients undergoing hematopoietic cell transplantation and for suppressing auto-reactive T cells of patients with auto-immune disorders. Its adoptive cell therapy candidates are based on the Company’s novel ex vivo cell programming approach, which it applies to modulate the therapeutic function and direct the fate of immune cells.

232JM, Process Development Engineer/Scientist

Job Code 232JM

Description

Fate Therapeutics is seeking an experienced and highly motivated cell therapy process development professional to lead scale up and cGMP compliant process development for new cellular immunotherapeutic candidates. This is a full-time position reporting to the Director of Process Development, and is located at our corporate headquarters in San Diego, CA. This position requires prior experience with mammalian cell culture, process development for cellular therapies, Quality Systems for biologics development, knowledge of statistical and analytical tools for process development, and excellent technical, organizational and interpersonal skills.

Download a PDF of the job description for more details:

View PDF

For consideration send cover letter and curriculum vitae to: careers@fatetherapeutics.com and reference job 232JM.

About Fate Therapeutics, Inc.

Fate Therapeutics is a biopharmaceutical company dedicated to the development of programmed cellular immunotherapeutics for the treatment of cancer and immune disorders. The Company’s cell-based product candidate pipeline is comprised of off-the-shelf immuno-oncology therapeutics, including NK- and T-cell-based candidates derived from induced pluripotent cells, and immuno-regulatory therapeutics, including hematopoietic cell-based candidates for protecting the immune system of patients undergoing hematopoietic cell transplantation and for suppressing auto-reactive T cells of patients with auto-immune disorders. Its adoptive cell therapy candidates are based on the Company’s novel ex vivo cell programming approach, which it applies to modulate the therapeutic function and direct the fate of immune cells.